Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 4 Neoplasm Metastasis 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Ovarian Neoplasms 2 Neoplasms 2 Leukemia, Myeloid, Chronic-Phase 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Brain Neoplasms 2 Vaping 1 Urinary Bladder Neoplasms 1 Tobacco Use Disorder 1 Stomach Neoplasms 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oligodendroglioma 1 Neoplasms by Histologic Type 1 NSCLC 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid 1 Leukemia 1 Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1 Hematologic Diseases 1

Interventions

Paclitaxel 95 Carboplatin 77 pembrolizumab 74 Cisplatin 29 Bevacizumab 27 Letrozole 22 Radiotherapy 21 Doxorubicin 21 Megestrol Acetate 20 lenvatinib 19 olaparib 18 Taxes 17 Docetaxel 17 Nivolumab 16 Specimen Handling 15 Metformin 15 dostarlimab 14 Magnetic Resonance Spectroscopy 14 Gemcitabine 13 durvalumab 12 Medroxyprogesterone Acetate 12 Trastuzumab 11 Indocyanine Green 11 Fulvestrant 11 Biopsy 11 temsirolimus 10 abemaciclib 10 atezolizumab 9 Radiation 9 Early Intervention, Educational 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × BID protein, human × Clear all

NCT06712472 2026-01-20

RAINBO-RED

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡